INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 177 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,571,683 | -17.7% | 49,370 | 0.0% | 0.02% | -13.0% |
| Q2 2023 | $3,126,108 | +20.6% | 49,370 | +3.1% | 0.02% | +21.1% |
| Q1 2023 | $2,592,215 | +0.5% | 47,871 | -1.7% | 0.02% | -9.5% |
| Q4 2022 | $2,578,104 | +13.7% | 48,717 | 0.0% | 0.02% | +10.5% |
| Q3 2022 | $2,266,802 | -16.5% | 48,717 | +2.4% | 0.02% | -13.6% |
| Q2 2022 | $2,715,981 | +4.4% | 47,582 | +11.9% | 0.02% | +29.4% |
| Q1 2022 | $2,601,493 | +104.1% | 42,515 | +74.6% | 0.02% | +54.5% |
| Q4 2021 | $1,274,741 | +29.2% | 24,355 | -8.0% | 0.01% | +22.2% |
| Q3 2021 | $986,652 | -8.7% | 26,466 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $1,080,342 | +20.3% | 26,466 | 0.0% | 0.01% | +11.1% |
| Q1 2021 | $897,991 | +6.7% | 26,466 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $841,619 | +23.9% | 26,466 | 0.0% | 0.01% | +28.6% |
| Q3 2020 | $679,118 | -0.0% | 26,466 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $679,382 | +90.0% | 26,466 | +13.8% | 0.01% | +60.0% |
| Q1 2020 | $357,583 | -46.8% | 23,265 | +18.7% | 0.01% | -28.6% |
| Q4 2019 | $672,682 | +359.3% | 19,606 | 0.0% | 0.01% | +250.0% |
| Q3 2019 | $146,457 | -42.4% | 19,606 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $254,486 | +6.6% | 19,606 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $238,801 | +6.9% | 19,606 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $223,312 | -47.5% | 19,606 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $425,450 | +23.0% | 19,606 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $346,000 | -16.2% | 19,606 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $413,000 | +67.9% | 19,606 | +15.4% | 0.01% | +66.7% |
| Q4 2017 | $246,000 | – | 16,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |